ArticleBlood cancer discovery2025

A Model of Intratumor and Interpatient Heterogeneity Explains Clinical Trials of Curative Combination Therapy for Lymphoma.

Amy E Pomeroy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.